☆ 4.5 Article

Oncological outcomes of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil for locally advanced squamous cell carcinoma of the external auditory canal: A single-center study

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2023)

相关参考文献

注意：仅列出部分参考文献，下载原文获取全部文献信息。

Article Otorhinolaryngology

Phase I trial of concurrent chemoradiotherapy with docetaxel, cisplatin and 5-fluorouracil (TPF-CRT) for locally advanced squamous cell carcinoma of the external auditory canal

Hirotaka Shinomiya et al.

Summary: Chemoradiotherapy with docetaxel, cisplatin, and 5-FU for locally advanced external auditory canal cancer has shown favorable outcomes. A phase I trial determined the recommended and maximum tolerated dose of docetaxel in this treatment regimen, with the RD and MTD determined to be 40 mg/m(2) when used alongside cisplatin and 5-FU.

EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY (2022)

添加到收藏夹

Article Otorhinolaryngology

Evaluation of subclasses for T4-classified squamous cell carcinoma of the external auditory canal

Cindy H. Nabuurs et al.

Summary: The study evaluated the impact of different subclasses of T4-classified squamous cell carcinoma of the external auditory canal on treatment strategies and survival outcomes. The results suggest that using different treatment strategies based on different subclasses may affect disease-free survival rates.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2022)

添加到收藏夹

Article Oncology

Hematopoietic Growth Factors, Version 1.2022 Featured Updates to the NCCN Guidelines

Elizabeth A. Griffiths et al.

Summary: The NCCN Guidelines provide recommendations for the appropriate use of growth factors in the management of certain conditions in adult patients with nonmyeloid malignancies. The guidelines aim to evaluate, prevent, and treat febrile neutropenia, chemotherapy-induced thrombocytopenia, and chemotherapy-induced anemia, allowing patients and clinicians to assess management options based on individual patient's condition. The recent updates emphasize the incorporation of a newly developed section on chemotherapy-induced thrombocytopenia.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2022)

添加到收藏夹

Article Medicine, Research & Experimental

Multi-institutional Survey of Squamous Cell Carcinoma of the External Auditory Canal in Japan

Kiyoto Shiga et al.

Summary: This study retrospectively analyzed the outcomes of 181 patients with advanced cancer of the external auditory canal who underwent chemoradiotherapy, with a focus on 74 patients who showed a 5-year survival rate of 54.6%. Results indicate favorable clinical outcomes for chemoradiotherapy in advanced EAC cancer, especially with the modified TPF regimen.

LARYNGOSCOPE (2021)

添加到收藏夹

Article Otorhinolaryngology

New proposal to revise the classification for squamous cell carcinoma of the external auditory canal and middle ear

H. Shinomiya et al.

Summary: This study investigated the clinical outcomes and prognostic factors of patients with squamous cell carcinoma of the external auditory canal and middle ear, revealing that invasion of the brain, carotid artery, and/or jugular vein in T-4 stage patients were significant predictors of poor prognosis. It is suggested to subclassify stage T-4 into T-4a and T-4b based on these prognostic factors.

JOURNAL OF LARYNGOLOGY AND OTOLOGY (2021)

添加到收藏夹

Article Oncology

Head and Neck Cancers, Version 2.2020

David G. Pfister et al.

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2020)

添加到收藏夹

Article Otorhinolaryngology

Clinical management for T1 and T2 external auditory canal cancer

Hirotaka Shinomiya et al.

AURIS NASUS LARYNX (2019)

添加到收藏夹

Article Otorhinolaryngology

Concomitant chemoradiotherapy for advanced squamous cell carcinoma of the temporal bone

Hirotaka Shinomiya et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2016)

添加到收藏夹

Review Otorhinolaryngology

Detecting Residual/Recurrent Head Neck Squamous Cell Carcinomas Using PET or PET/CT: Systematic Review and Meta-analysis

Phylannie K. F. Cheung et al.

OTOLARYNGOLOGY-HEAD AND NECK SURGERY (2016)

添加到收藏夹

Article Clinical Neurology

The Outcomes of Surgery and Chemoradiotherapy for Temporal Bone Cancer

Shinya Morita et al.

OTOLOGY & NEUROTOLOGY (2016)

添加到收藏夹

Article Oncology

Recommendations for the Use of WBC Growth Factors: American Society of Clinical Oncology Clinical Practice Guideline Update

Thomas J. Smith et al.

JOURNAL OF CLINICAL ONCOLOGY (2015)

添加到收藏夹

Review Otorhinolaryngology

Chemoradiation therapy for squamous cell carcinoma of the external auditory canal: A meta-analysis

Yukinori Takenaka et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2015)

添加到收藏夹

Article Oncology

Concurrent Chemoradiotherapy with Docetaxel, Cisplatin and 5-Fluorouracil (TPF) in Patients with Locally Advanced Squamous Cell Carcinoma of the Head and Neck

Masanori Komatsu et al.

JAPANESE JOURNAL OF CLINICAL ONCOLOGY (2014)

添加到收藏夹

Article Clinical Neurology

Concomitant Chemoradiotherapy as a Standard Treatment for Squamous Cell Carcinoma of the Temporal Bone

Kiyoto Shiga et al.

SKULL BASE-AN INTERDISCIPLINARY APPROACH (2011)

添加到收藏夹

Article Oncology

Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck

Mamoru Tsukuda et al.

CANCER CHEMOTHERAPY AND PHARMACOLOGY (2010)

添加到收藏夹

Article Oncology

Radiation Treatment Interruptions Greater Than One Week and Low Hemoglobin Levels (12 g/dL) are Predictors of Local Regional Failure After Definitive Concurrent Chemotherapy and Intensity-Modulated Radiation Therapy for Squamous Cell Carcinoma of the Head and Neck

Susan A. McCloskey et al.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2009)

添加到收藏夹

Article Medicine, Research & Experimental

Poor Radiotherapy Compliance Predicts Persistent Regional Disease in Advanced Head/Neck Cancer

Urjeet A. Patel et al.

LARYNGOSCOPE (2009)

添加到收藏夹

Article Otorhinolaryngology

Cancer of the external auditory canal and middle ear in Denmark from 1992 to 2001

Anders Rorbaek Madsen et al.

HEAD AND NECK-JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK (2008)

添加到收藏夹

Article Medicine, General & Internal

Cisplatin and fluorouracil alone or with docetaxel in head and neck cancer

Marshall R. Posner et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

添加到收藏夹

Article Medicine, General & Internal

Cisplatin, fluorouracil, and docetaxel in unresectable head and neck cancer

Jan B. Vermorken et al.

NEW ENGLAND JOURNAL OF MEDICINE (2007)

添加到收藏夹

Article Otorhinolaryngology

Analysis of 95 cases of squamous cell carcinoma of the external and middle ear

Min Yin et al.

AURIS NASUS LARYNX (2006)

添加到收藏夹

Article Medicine, Research & Experimental

The outcome of radical surgery and postoperative radiotherapy for squamous carcinoma of the temporal bone

DA Moffat et al.

LARYNGOSCOPE (2005)

添加到收藏夹

© Peeref 2019-2024. All rights reserved.